Clinical Trial Update: A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates Cadonilimab in combination with Regorafenib for advanced hepatocellular carcinoma that has failed at least one prior systemic th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cadonilimab
• Regorafenib (regorafenib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Advanced Hepatocellular Carcinoma That Has Failed at Least One Prior Systemic Therapy | Phase 1 | Status: ACTIVE_NOT_RECRUITING